Little Rock, AR, United States of America

Stavros C Manolagas

This inventor holds 2 USPTO granted patents. Top assignee: University of Arkansas. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stavros C Manolagas. Retrieved from https://idiyas.com/inventor/stavros-c-manolagas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Bone Health: The Contributions of Stavros C Manolagas

Introduction

Stavros C Manolagas is a prominent inventor based in Little Rock, AR (US), known for his significant contributions to the field of bone health. With a focus on understanding and preventing glucocorticoid-induced bone destruction, he has developed innovative solutions that address critical issues in osteoporosis treatment. His work has led to the issuance of 2 patents, showcasing his commitment to advancing medical science.

Latest Patents

Manolagas' latest patents include groundbreaking inventions aimed at improving bone health. One of his notable patents is titled "Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction." This invention reveals that glucocorticoid-induced bone disease results from alterations in the birth and death rates of bone cells. Utilizing a murine model of glucocorticoid excess and bone biopsy specimens from patients, the invention demonstrates that glucocorticoid administration increases apoptosis of mature osteoblasts and osteocytes while decreasing bone formation rates and mineral density.

Another significant patent is "Increasing bone strength with selected bisphosphonates." This invention outlines a method and composition to enhance bone strength, potentially reducing fracture incidence. It involves administering an effective amount of a bisphosphonate to inhibit the apoptosis of osteoblasts and osteocytes, thereby promoting an anabolic effect on bone mass and strength.

Career Highlights

Stavros C Manolagas is affiliated with the University of Arkansas, where he conducts research and develops innovative solutions for bone health. His work has garnered attention in the scientific community, contributing to advancements in osteoporosis treatment and bone health management.

Collaborations

Throughout his career, Manolagas has collaborated with esteemed colleagues, including Teresita Bellido and Robert L Jilka. These collaborations have further enriched his research and expanded the impact of his inventions in the field of bone health.

Conclusion

Stavros C Manolagas is a distinguished inventor whose work has significantly advanced the understanding and treatment of bone health issues. His innovative patents reflect a deep commitment to improving patient outcomes in osteoporosis and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…